UCB - Cost Of Sales

Stock Price
265.45
Daily Change
-2.35 -0.88%
Monthly
0.82%
Yearly
97.14%
Q2 Forecast
257.81

UCB reported EUR1.07B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Alcon AG USD 1.2B 46M Dec/2025
Almirall EUR 191.5M 2.29M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Orion EUR 186.6M 17.6M Dec/2025
Recordati EUR 199.91M 20.12M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 1.07B 146M Dec/2025
Unibail Rodamco EUR 546.4M 9.4M Dec/2025